OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitors
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105964-105964
Closed Access | Times Cited: 19
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105964-105964
Closed Access | Times Cited: 19
Showing 19 citing articles:
New pyrazolopyridine and pyrazolothiazole-based compounds as anti-proliferative agents targeting c-Met kinase inhibition: design, synthesis, biological evaluation, and computational studies
Zahra M. Al-Amshany, Eman M. Algamdi, Ismail M. M. Othman, et al.
RSC Advances (2023) Vol. 13, Iss. 19, pp. 12889-12905
Open Access | Times Cited: 22
Zahra M. Al-Amshany, Eman M. Algamdi, Ismail M. M. Othman, et al.
RSC Advances (2023) Vol. 13, Iss. 19, pp. 12889-12905
Open Access | Times Cited: 22
Recent advances in the synthesis and utility of thiazoline and its derivatives
Sumit Kumar, Aditi Arora, Shivani Sapra, et al.
RSC Advances (2024) Vol. 14, Iss. 2, pp. 902-953
Open Access | Times Cited: 8
Sumit Kumar, Aditi Arora, Shivani Sapra, et al.
RSC Advances (2024) Vol. 14, Iss. 2, pp. 902-953
Open Access | Times Cited: 8
Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present)
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access
Design, synthesis, and in silico studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects
Aisha A. Alsfouk, Ismail M. M. Othman, Manal M. Anwar, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 1407-1424
Open Access
Aisha A. Alsfouk, Ismail M. M. Othman, Manal M. Anwar, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 1407-1424
Open Access
Novel pyridine-thiazolidinone-triazole hybrid glycosides targeting EGFR and CDK-2: Design, synthesis, anticancer evaluation, and molecular docking simulation
Asmaa F. Kassem, Mohamed A. Omar, Eman S. Nossier, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136358-136358
Closed Access | Times Cited: 17
Asmaa F. Kassem, Mohamed A. Omar, Eman S. Nossier, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136358-136358
Closed Access | Times Cited: 17
Green Synthesis of Aromatic Nitrogen-Containing Heterocycles by Catalytic and Non-Traditional Activation Methods
Rita Bernadett Vlocskó, Guoshu Xie, Béla Török
Molecules (2023) Vol. 28, Iss. 10, pp. 4153-4153
Open Access | Times Cited: 15
Rita Bernadett Vlocskó, Guoshu Xie, Béla Török
Molecules (2023) Vol. 28, Iss. 10, pp. 4153-4153
Open Access | Times Cited: 15
A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target
Ajaya Kumar Rout, Budheswar Dehury, Satya Narayan Parida, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132030-132030
Closed Access | Times Cited: 4
Ajaya Kumar Rout, Budheswar Dehury, Satya Narayan Parida, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132030-132030
Closed Access | Times Cited: 4
New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation
Wael A. El‐Sayed, Fahad M. Alminderej, Marwa M. Mounier, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5688-5688
Open Access | Times Cited: 25
Wael A. El‐Sayed, Fahad M. Alminderej, Marwa M. Mounier, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5688-5688
Open Access | Times Cited: 25
Cd(II) complexes derived from thiazoline, hydrazide and carbodithioate ligands: synthesis, crystal structures and electrochemical sensing of uric acid
Shubham Jaiswal, Shivendra Kumar Pandey, Jyoti Prajapati, et al.
Applied Organometallic Chemistry (2023) Vol. 37, Iss. 5
Closed Access | Times Cited: 12
Shubham Jaiswal, Shivendra Kumar Pandey, Jyoti Prajapati, et al.
Applied Organometallic Chemistry (2023) Vol. 37, Iss. 5
Closed Access | Times Cited: 12
EGFR as therapeutic target to develop new generation tyrosine kinase inhibitors against breast cancer: A critical review
Ruby Mariam Raju, Jeffin Joy A, Raghavendra Nulgumnalli Manjunathaiah, et al.
Results in Chemistry (2024) Vol. 7, pp. 101490-101490
Open Access | Times Cited: 3
Ruby Mariam Raju, Jeffin Joy A, Raghavendra Nulgumnalli Manjunathaiah, et al.
Results in Chemistry (2024) Vol. 7, pp. 101490-101490
Open Access | Times Cited: 3
A decade's overview of 2‐aminothiophenes and their fused analogs as promising anticancer agents
Donia G. Darwish, Hany A.M. El-Sherief, Salah A. Abdel‐Aziz, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 6
Closed Access | Times Cited: 2
Donia G. Darwish, Hany A.M. El-Sherief, Salah A. Abdel‐Aziz, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 6
Closed Access | Times Cited: 2
New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity
Hebat‐Allah S. Abbas, Eman S. Nossier, May A. El‐Manawaty, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Hebat‐Allah S. Abbas, Eman S. Nossier, May A. El‐Manawaty, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
A versatile precursor for one‐pot synthesis of novel azo‐thiazole and thiazole scaffolds as prospective antimicrobial and antioxidant agents
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman
Journal of the Chinese Chemical Society (2024) Vol. 71, Iss. 10, pp. 1309-1323
Open Access | Times Cited: 2
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman
Journal of the Chinese Chemical Society (2024) Vol. 71, Iss. 10, pp. 1309-1323
Open Access | Times Cited: 2
Pyridine-Based Glycosides Bearing 1,2,4-Triazole and Their 1,3,4-oxadiazole analogues as Potential EGFR and CDK-2 Inhibitors: Design, Synthesis, Antiproliferative Activity and In Silico Studies
Asmaa F. Kassem, Ahmed Younis, Eman S. Nossier, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138741-138741
Closed Access | Times Cited: 1
Asmaa F. Kassem, Ahmed Younis, Eman S. Nossier, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138741-138741
Closed Access | Times Cited: 1
Design of Sulfonamide-Based Glycosides Incorporated with 1,2,3-Triazole Scaffold as Potential VEGFR-2 and Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxic Activity and In Silico Studies
Mohamed N. El-Bayaa, Eman S. Nossier, May A. El‐Manawaty, et al.
Research Square (Research Square) (2024)
Open Access
Mohamed N. El-Bayaa, Eman S. Nossier, May A. El‐Manawaty, et al.
Research Square (Research Square) (2024)
Open Access
Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access
Novel quinazolin-4-one based derivatives bearing 1,2,3-triazole and glycoside moieties as potential cytotoxic agents through dual EGFR and VEGFR-2 inhibitory activity
Adel A.‐H. Abdel‐Rahman, Mohamed N. El-Bayaa, Asmaa Sobhy, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Adel A.‐H. Abdel‐Rahman, Mohamed N. El-Bayaa, Asmaa Sobhy, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
New Class of Thienopyridines: Design, Synthesis, Antimicrobial Activity and Molecular Docking Study
Azhaar T. Alsaggaf, Mostafa Sayed, Ahmed A . Dewan, et al.
Journal of Molecular Structure (2024) Vol. 1323, pp. 140741-140741
Closed Access
Azhaar T. Alsaggaf, Mostafa Sayed, Ahmed A . Dewan, et al.
Journal of Molecular Structure (2024) Vol. 1323, pp. 140741-140741
Closed Access
New pyrano-pyridine conjugates as potential anticancer agents: design, synthesis and computational studies
Aladdin M. Srour, Eman S. Nossier, Najla Altwaijry, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2567-2582
Closed Access
Aladdin M. Srour, Eman S. Nossier, Najla Altwaijry, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2567-2582
Closed Access